Author

Shuai Ding

Nanjing Drum Tower HospitalORCID 0009-0009-0855-356XUnclaimed ORCID profile · follow to get notified of new preprints

Additional preprints under this name without ORCID

Shuai Ding1 paper · Zhengzhou University

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Approach:experimental assay· 2 Organism:mouse· 2 Research Focus:benchmarking· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1

Frequent Co-Authors

Shuang LiuiD· 2 shared Yan LiiD· 2 shared C. Yan ChengiD· 1 shared Chun‐Yi LuiD· 1 shared Daniel HirschhorniD· 1 shared Deshan ReniD· 1 shared Dongquan ShiiD· 1 shared Haiqiao SuniD· 1 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 33 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

Shuang LiuORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

ImmunologybioRxivPreprintJan 29, 2026

An Advanced Humanized Systemic Lupus Erythematosus Model Enables Parallel Profiling of B Cell-Targeted Therapies

Rujie Zhu, Shuai Ding, Deshan Ren…·Li Sun

This study develops a humanized SLE model to compare B cell-targeted therapies, finding UCAR-T provides better renal and autoantibody reduction than TCEs despite higher toxicity.

1 citation

mouseexperimental assay

𝕏 PostBluesky

ImmunologyCell ResearchPeer-reviewedJul 15, 2025

Human myelocyte and metamyelocyte-stage neutrophils suppress tumor immunity and promote cancer progression

Wei Liu, Tao Shi, Chun‐Yi Lu…·Yan Li

The paper identifies human myelocyte and metamyelocyte-stage neutrophils as immunosuppressive cells that promote cancer progression and suggests targeting them for immunotherapy.

15 citationstop 3%

𝕏 PostBluesky